Integrated care: Utilisation of complementary and alternative medicine within a conventional cancer treatment centre

被引:24
作者
Gage, Heather [2 ]
Storey, Lesley [1 ]
McDowell, Charlotte [3 ]
Maguire, Gail [3 ]
Williams, Peter [4 ]
Faithfull, Sara [5 ]
Thomas, Hilary
Poole, Karen [6 ]
机构
[1] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland
[2] Univ Surrey, Dept Econ, Guildford GU2 7XH, Surrey, England
[3] Royal Surrey Cty Hosp, Fountain Ctr, Guildford GU2 7XX, Surrey, England
[4] Univ Surrey, Dept Math & Stat, Guildford GU2 7XH, Surrey, England
[5] Univ Surrey, European Inst Hlth & Med Sci, Guildford GU2 7XH, Surrey, England
[6] Royal Surrey Cty Hosp, St Lukes Canc Ctr, Guildford GU2 7XX, Surrey, England
关键词
Integration; Oncology; Utilisation; CAM (complementary and alternative medicine); BREAST-CANCER; THERAPY USE; WOMEN; POPULATION; PREVALENCE; PATIENT;
D O I
10.1016/j.ctim.2008.09.001
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objectives: To estimate the proportion of cancer outpatients who visit a Complementary and Alternative Medicine (CAM) unit that is located within a conventional cancer treatment centre; to compare the characteristics of CAM unit visitors with those of all outpatients; to monitor the demand for 20 CAM therapies delivered by professionals, and the use of the CAM unit for waiting, gathering information and informal support from volunteer staff. Design: Prospective, observational, over a six month period. Setting: CAM unit within a NHS cancer treatment centre. Main outcome measures: Utilisation of the CAM unit for 20 complementary therapies, and for waiting, gathering information, informal support; characteristics of CAM users compared with those of all cancer outpatients attending the cancer centre; predictors of CAM therapy use and frequent use. Results: 761 (95% of those approached) people were recruited, 498 (65.4%) cancer patients, 202 (26.5%) relatives, 37 (4.8%) friends/carers, 24 (3.2%) staff. Women predominated (n = 560, 73.6%). Of all outpatients attending the cancer centre, 498 (15.8%) visited the CAM unit, 290 (9.2%) accessed therapies. Compared to all outpatients, those visiting the CAM unit were: younger (mean 63.7 vs. 58.4 years), more likely to be female (57.9% vs. 78.7%), have breast (14.8% vs. 51.9%), gynaecotogical (5.0% vs. 9.1%) cancer, live in local postal district (57.3% vs. 61.6%). Significant predictors of therapy use and frequent visits were being a patient, female, higher education, living closer to the cancer centre. Conclusions: Despite easy access to CAM therapies, a relatively small number of people regularly used them, whilst a larger number selectively tried a few. The integrated CAM unit meets a demand for information and informal support. The findings inform emerging policy on integrating CAM and conventional cancer treatment to address psychosocial needs of people with cancer. More research is needed on why people do not use integrated CAM services and how charges affect demand. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:84 / 91
页数:8
相关论文
共 36 条
  • [1] Adler SR, 1999, J FAM PRACTICE, V48, P453
  • [2] [Anonymous], 2004, IMPR SUPP PALL CAR A
  • [3] Patterns of alternative medicine use by cancer patients
    Begbie, SD
    Kerestes, ZL
    Bell, DR
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (10) : 545 - 548
  • [4] Bell L, 1996, Complement Ther Nurs Midwifery, V2, P57, DOI 10.1016/S1353-6117(96)80095-3
  • [5] Bennett M, 1999, Oncol Nurs Forum, V26, P1287
  • [6] Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): Making the decision to use or not to use
    Boon, H
    Brown, JB
    Gavin, A
    Kennard, MA
    Stewart, M
    [J]. QUALITATIVE HEALTH RESEARCH, 1999, 9 (05) : 639 - 653
  • [7] Discussing complementary therapies with cancer patients: What should we be talking about?
    Burstein, HJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) : 2501 - 2504
  • [8] Use of alternative medicine by women with early-stage breast cancer
    Burstein, HJ
    Gelber, S
    Guadagnoli, E
    Weeks, JC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (22) : 1733 - 1739
  • [9] CANTER P, 2005, BRIT MED J, V331, P857
  • [10] Cassileth BR, 1999, CANCER, V86, P1900, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1900::AID-CNCR4>3.3.CO